Technical feasibility and safety profile of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT)
- PMID: 25445838
- PMCID: PMC4460271
- DOI: 10.1007/s11695-014-1518-1
Technical feasibility and safety profile of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT)
Abstract
Background: In this study, we specifically aimed to analyze the technical and safety aspects of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT) in patients with type 2 diabetes (T2DM).
Methods: A total of 360 patients with type 2 diabetes who underwent a DSIT procedure within the past 2-year period (2011-2013) were analyzed. Operation time, length of hospital stay, perioperative and postoperative complications, and mortality were recorded and analyzed.
Results: The participants consisted of 229 males (63.6 %) and 131 females (36.4 %). Mean duration of follow-up was 12.4 months (range, 6-31). One early and two late mortalities occurred. Early mortality was due to an anastomotic leak, and late mortalities were related to myocardial infarction and a traffic accident. Leakage and bleeding were the most common surgical complications. The total number of surgical complications was 22 (6.1 %). Of those, 19 occurred within the first month (early) and 3 occurred after the first month (late). Among early complications, seven (1.94 %) required re-operation, two patients (0.55 %) required endoscopic treatment, and the remaining ten were managed conservatively. Late surgical complications (sleeve angulation) were noted in three patients (0.83) and were treated by endoscopic stents. Surgery-related non-surgical complications occurred in 19 cases (5.2 %), and neurological complications were noted in 11 patients (3.05 %). Additional surgical intervention was required in 26 patients (7.22 %). Of those, 15 (4.16 %) required cholecystectomy.
Conclusions: Our data demonstrate that DSIT is a technically feasible operation and can be safely performed in type 2 diabetic patients with acceptable complication and mortality rates.
Conflict of interest statement
Authors declare no conflict of interest.
Figures
References
-
- American Diabetes Association, The dangerous toll of diabetes. http: //www.diabetes.org/diabetes-statistics/dangerous-toll.jsp.
-
- Bermudez DM, Pories WJ. New technologies for treating obesity. Minerva Endocrinol. 2013;38:165–72. - PubMed
-
- Dejardin DC, Sabench F, Hernandez GMA, et al. Effectiveness of sleeve gastrectomy as type 2 diabetes treatment: relationship with the technique and complications. In Diabetes Surgery Eds: Garciacaballero M, Tinahones FJ, Cohen RV. McGraw Hill publication. 2010, 195–206.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous